498 related articles for article (PubMed ID: 32044312)
1. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
2. Contraception across the transmasculine spectrum.
Krempasky C; Harris M; Abern L; Grimstad F
Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
4. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gomez-Lobo V; Gray M
Am J Obstet Gynecol; 2019 Mar; 220(3):257.e1-257.e7. PubMed ID: 30579875
[TBL] [Abstract][Full Text] [Related]
5. One-third of amenorrheic transmasculine people on testosterone ovulate.
Asseler JD; Del Valle JS; Chuva de Sousa Lopes SM; Verhoeven MO; Goddijn M; Huirne JAF; van Mello NM
Cell Rep Med; 2024 Mar; 5(3):101440. PubMed ID: 38402622
[TBL] [Abstract][Full Text] [Related]
6. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
Lierman S; Tolpe A; De Croo I; De Gheselle S; Defreyne J; Baetens M; Dheedene A; Colman R; Menten B; T'Sjoen G; De Sutter P; Tilleman K
Fertil Steril; 2021 Oct; 116(4):1068-1076. PubMed ID: 33832736
[TBL] [Abstract][Full Text] [Related]
7. Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care.
Tordoff DM; Wanta JW; Collin A; Stepney C; Inwards-Breland DJ; Ahrens K
JAMA Netw Open; 2022 Feb; 5(2):e220978. PubMed ID: 35212746
[TBL] [Abstract][Full Text] [Related]
8. A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.
Kinnear HM; Constance ES; David A; Marsh EE; Padmanabhan V; Shikanov A; Moravek MB
Hum Reprod; 2019 Oct; 34(10):2009-2017. PubMed ID: 31585007
[TBL] [Abstract][Full Text] [Related]
9. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gray M; Gomez Lobo V
J Sex Med; 2020 Sep; 17(9):1807-1818. PubMed ID: 32703706
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
[TBL] [Abstract][Full Text] [Related]
12. A mouse model mimicking gender-affirming treatment with pubertal suppression followed by testosterone in transmasculine youth.
Dela Cruz C; Kinnear HM; Hashim PH; Wandoff A; Nimmagadda L; Chang FL; Padmanabhan V; Shikanov A; Moravek MB
Hum Reprod; 2023 Feb; 38(2):256-265. PubMed ID: 36484619
[TBL] [Abstract][Full Text] [Related]
13. HIV prevalence among transmasculine individuals at a New York City Community Health Centre: a cross-sectional study.
Radix AE; Larson EL; Harris AB; Chiasson MA
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25981. PubMed ID: 36225145
[TBL] [Abstract][Full Text] [Related]
14. Testosterone use and sexual function among transgender men and gender diverse people assigned female at birth.
Tordoff DM; Lunn MR; Chen B; Flentje A; Dastur Z; Lubensky ME; Capriotti M; Obedin-Maliver J
Am J Obstet Gynecol; 2023 Dec; 229(6):669.e1-669.e17. PubMed ID: 37678647
[TBL] [Abstract][Full Text] [Related]
15. Incidence of breakthrough bleeding in transgender and gender-diverse individuals on long-term testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
Am J Obstet Gynecol; 2024 Apr; 230(4):434.e1-434.e10. PubMed ID: 38181830
[TBL] [Abstract][Full Text] [Related]
16. Expected vs. perceived effects of gender-affirming hormone therapy among transmasculine adolescents.
Taillefer V; Kelley J; Marsolais S; Chiniara L; Chadi N
J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1072-1078. PubMed ID: 37747085
[TBL] [Abstract][Full Text] [Related]
17. Experience of Chest Dysphoria and Masculinizing Chest Surgery in Transmasculine Youth.
Mehringer JE; Harrison JB; Quain KM; Shea JA; Hawkins LA; Dowshen NL
Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33536330
[TBL] [Abstract][Full Text] [Related]
18. Top Surgery and Chest Dysphoria Among Transmasculine and Nonbinary Adolescents and Young Adults.
Ascha M; Sasson DC; Sood R; Cornelius JW; Schauer JM; Runge A; Muldoon AL; Gangopadhyay N; Simons L; Chen D; Corcoran JF; Jordan SW
JAMA Pediatr; 2022 Nov; 176(11):1115-1122. PubMed ID: 36156703
[TBL] [Abstract][Full Text] [Related]
19. Chest Reconstruction and Chest Dysphoria in Transmasculine Minors and Young Adults: Comparisons of Nonsurgical and Postsurgical Cohorts.
Olson-Kennedy J; Warus J; Okonta V; Belzer M; Clark LF
JAMA Pediatr; 2018 May; 172(5):431-436. PubMed ID: 29507933
[TBL] [Abstract][Full Text] [Related]
20. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
